Abstract
Background:
The study aimed to evaluate local and national trends in immediate breast reconstruction (IBR) using the national English administrative records, Hospital Episode Statistics. Our prediction was an increase in implant-only and free flap procedures and a decline in latissimus flap reconstructions.
Methods:
Data from an oncoplastic center were interrogated to derive numbers of implant-only, autologous latissimus dorsi (LD), LD-assisted, and autologous pedicled or free flap IBR procedures performed between 2004 and 2013. Similarly, Hospital Episode Statistics data were used to quantify national trends in these procedures from 1996 to 2012 using a curve fitting analysis.
Results:
National data suggest an increase in LD procedures between 1996 (n = 250) and 2002 (n = 958), a gradual rise until 2008 (n = 1398) followed by a decline until 2012 (n = 1090). As a percentage of total IBR, trends in LD flap reconstruction better fit a quadratic (R2 = 0.97) than a linear function (R2 = 0.63), confirming a proportional recent decline in LD flap procedures. Conversely, autologous (non-LD) flap reconstructions have increased (1996 = 0.44%; 2012 = 2.76%), whereas implant-only reconstructions have declined (1996 = 95.42%; 2012 = 84.92%). Locally, 70 implant-assisted LD procedures were performed in 2003 -2004, but only 2 were performed in 2012 to 2013.
Conclusions:
Implants are the most common IBR technique; autologous free flap procedures have increased, and pedicled LD flap procedures are in decline.
Immediate breast reconstruction (IBR) is associated with improved quality of life, body image, self-esteem, and confidence1,2 and has become an increasingly popular choice among patients undergoing mastectomy.2,3 IBR techniques fall into 2 broad categories: (1) implant-only reconstruction performed either as a two-stage procedure with tissue expansion followed by exchange for a fixed-volume implant or as a single-stage direct to fixed-volume implant procedure and (2) autologous reconstruction necessitating either pedicled flaps [eg, latissimus dorsi (LD) myocutaneous flap] or free tissue transfer [eg, deep inferior epigastric perforator (DIEP) flap]. Of the autologous approaches to IBR, the LD myocutaneous flap, often regarded as the ‘workhorse’ of reconstructive breast surgery in the United Kingdom, has enjoyed popularity owing to its relative simplicity and versatility. In suitable candidates, an extensive dissection to maximize tissue harvest can facilitate an entirely autologous reconstruction, known as the “extended LD,” which avoids complications of abdominal tissue harvesting such as abdominal bulge and hernia. A more common strategy is to use the LD muscle flap to provide additional soft-tissue coverage for implant-based reconstruction (implant-assisted LD), with the goal of superior cosmetic outcomes when compared with musculofascial coverage utilizing the pectoralis major and serratus anterior muscles in isolation. With the development of microvascular surgery enabling fasciocutaneous flaps to be raised, sparing muscle pedicles to derive its blood supply, an intuitive prediction of practice trends would be a reduction in the number of procedures associated with muscle harvest such as the LD, given its attendant morbidity.
Donor-site complications that arise after IBR with the LD include donor-site seroma, pain from scarring,4–8 and muscle weakness of the shoulder girdle.9–11 Improvements in the reliability, durability, and consistency of IBR using free flaps such as the DIEP flap have resulted in better complication profiles of autologous reconstruction.12 The addition of acellular dermal matrices (ADM) to implant reconstruction facilitates a single-stage “direct to implant” procedure,13 by improving implant cover, better inframammary fold definition, and reducing capsule formation after prosthetic BR.13 In our practice, we have observed patients selecting expander or implant reconstruction, with or without ADM, or alternatively autologous techniques involving abdominal tissue transfer, rather than the LD per se.
Our hypothesis is that a recent shift has occurred toward a pattern of IBR practice that is less reliant on the LD flap. Declining trends in IBR techniques has important implications for councils for graduate medical education in establishing benchmark caseloads for residents to be credentialed in reconstructive surgery and may help inform commissioning of reconstructive services. To test our hypothesis, an analysis of the number of IBR procedures performed every year over the last 10 years was conducted using data from our institution and a Hospital Episode Statistics (HES) database, which covers all National Health Service (NHS) hospitals in England, to evaluate similarities in IBR trends.
MATERIALS AND METHODS
Tertiary Center Referral Data
The Royal Marsden NHS Trust (RMH) is a specialist oncoplastic center, receiving approximately 1000 new breast cancer referrals and performing approximately 150 IBR procedures every year. A search of the local procedure–coded database and administrative systems at this institution was conducted to identify patients undergoing mastectomy and immediate reconstruction from April 1, 2003, to July 31, 2013. Similar search criteria were used to interrogate national data available from HES (Table 1). Crude procedural numbers were derived and categorized according to the type of reconstructive procedure(s) based on specified sets of codes from the Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures (OPCS-4).
Table 1.
Categorization of Immediate Breast Reconstruction by OPCS codes
HES and Data Extraction Methodology
Hospital Episode Statistics is an administrative data set that collates data pertaining to patients admitted to NHS hospitals in England. Admissions contain both diagnostic and up to 24 procedure fields, coded using the OPCS system. HES data were analyzed to include all patients undergoing mastectomy in combination with a reconstructive procedure between April 1, 1996, and April 1, 2013. Data were categorized according to the type of reconstructive procedure as defined in Table 1. The combination of mastectomy and simultaneous reconstruction ensured that the current analysis was restricted to practices in immediate reconstruction.
Procedures that included the OPCS code for LD flap (B29.1) without any other OPCS code were assumed to represent extended LD procedures. Implant-assisted LD procedures were identified by the presence of the OPCS code for LD flap in combination with any code for expanders, implants, and/or theater devices (S48.2, B30.1, B30.8, B30.9, T85.2, T86.2, T87.3, T91.1). Similarly, implant- or expander-only reconstructions were identified by the presence of their respective OPCS codes in the absence of other reconstruction codes. There is currently no OPCS code specific for ADM; hence, the frequency of ADM-based reconstruction could not be ascertained. Autologous tissue flaps were predominantly derived from the lower abdominal pannus; in accordance with modern surgical practice, we focused on DIEP reconstructions. However, the OPCS code specific for DIEP (B39.3) was employed only from March 2006 onward. Before March 2006, a single OPCS code (B29.3) was used to define reconstruction of the breast using “free” or “pedicled” transverse rectus abdominis myocutaneous (TRAM) flap, other specified reconstruction using lower abdomen, and unspecified reconstruction using the lower abdomen. We, therefore, describe these procedures as “abdominal flaps”; given procedural heterogeneity, the inability to dissect trends in different abdominal flap procedures and the nature of hypothesis, that is, trends in LD versus autologous abdominal flap procedures. There is currently no OPCS code for transverse gracilis myocutaneous flap and therefore a code describing breast reconstruction “other specified” (B29.8) was used. Bilateral procedures were not considered separately.
Curve Fitting Analysis
Curve fitting is a method for finding the best-fit line to a set of data points. Lines of “best-fit” were computed to determine whether trends in the proportion of LD flap reconstruction better fit a linear or quadratic, that is, parabolic, function. If as predicted, free flap and implant-only reconstructions have increased and as a proportion of total IBR practice LD flap reconstructions have decreased, then the data should better fit a quadratic than a linear function. Data were analyzed using IBM SPSS Statistics (Version 22, IBM).
RESULTS
Local Specialist Center
As illustrated in Figure 1 and Table 2, a steady decline in the number of IBRs involving LD flap harvest at our institution was observed. For example, in the year 2004–2005, the unit performed 70 postmastectomy LD-assisted reconstructions (of 125 IBRs); by 2009–2010, this figure had already fallen to 18 (of 155 IBRs); and by 2012–2013, only 2 procedures (of 176 IBRs) involved an implant-assisted LD flap. By comparison, over the same time period, implant-only and autologous abdominal flap procedures increased. In 2004–2005, 35 expander-implant procedures and 11 DIEP reconstructions were performed at the RMH, and by 2012–2013, the annual number of these procedures had increased to 98 and 67, respectively. In 2003–2004, LD-assisted reconstructions represented just over half (54%) of total IBR practice volume at the RMH, whereas in 2012–2013, it represented only 1%. Conversely, as a proportion of total practice volume, DIEP flap reconstructions have substantially increased from 9% in 2003–2004 to 38% in 2012–2013.
Fig. 1.
Longitudinal variation in subcategories of immediate breast reconstruction performed at the Royal Marsden NHS Foundation Trust 2004–2013. Data episodes arranged sequentially according to financial year(s), such that 2004 data = number of reconstructive procedures performed from April 5, 2003, to April 5, 2004; 2005 data = April 5, 2004, to April 5, 2005, etc. LD Expander indicates latissimus dorsi plus expander/implant.
Table 2.
Trends in Immediate Breast Reconstruction 2003–2013 at the Royal Marsden NHS Foundation Trust
National Hospital Episode Data
To distinguish between local practice variations and a national epidemiological shift, HES data were interrogated to determine whether a decline in LD reconstruction was mirrored across units in England. HES data (Table 3) suggest that the numbers of IBR have doubled from 8389 in 1996 to 16,430 in 2012. As a percentage of immediate IBR practice, year on year, expander/implant reconstructions remain the most frequently practiced procedure (ie, accounting for >85% of IBR volume). However, longitudinal trends suggest a proportional increase in DIEP flap reconstructions (1996 = 0.44%, 2007 = 1.37%, 2012 = 2.76%), a steady decline in implant-only reconstruction (1996 = 95.42%, 2007 = 87.17%, 2012 = 84.92%), and a more recent decline in LD flap procedures commensurate with local data (1996 = 2.89%, 2007 = 7.81%, 2012 = 6.22%). HES data suggest that between 1996 and 2012, LD reconstructions comprised <10% of all reconstructive practice. Even at the height of popularity (2008–2009), LD reconstructions represented only 8% of total IBR practice.
Table 3.
National Trends in Immediate Breast Reconstruction 1996–2012
National Trend Analysis: Curve Fitting
As highlighted in Figure 2A, crude rates of LD-expander procedures have increased linearly. However, Figure 2B demonstrates that the proportion of LD reconstructions better fit a parabola rather than a linear function. The results of curve fitting confirm that the percentage of LD breast reconstruction better fits a quadratic (R2 = 0.97; p < 0.001) as opposed to a linear function (R2 = 0.63; p < 0.001). We further explored HES data by individual unit. Commensurate with local data, a declining trend in LD procedures (2003–2012) was identified for a number of NHS Trusts (n = 33). As illustrated in Figure 3A–D, this trend was observed in both oncoplastic units and specialist oncoplastic centers with same-site oncological and reconstruction services.
Fig. 2.
Longitudinal trends in National LD flap immediate breast reconstruction rates for financial years 1996–2012. A, Charts highlight trends in LD-expander rates. B, Proportion of LD flap procedures expressed as a percentage of the total postmastectomy breast reconstruction load. Lines of “best-fit” for linear and quadratic functions are superimposed.
Fig. 3.
Trends in the crude numbers of implant-assisted LD flap reconstructions across 4 UK NHS Trusts, 1996–2012. The plots for NHS Trusts reflect a similar trend to that observed at the Royal Marsden NHS Foundation Trust (2003–2012): RP5 Doncaster and Basseltow NHS Trust (A); RNZ Salisbury NHS Trust (B); RVJ North Bristol NHS Trust (C); and RYQ South London Healthcare NHS Trust (D).
DISCUSSION
This study demonstrates that as a percentage of total IBR practice, immediate LD flap reconstructions are in substantial decline in specialist centers and in recent decline in the United Kingdom in general. Implant-only reconstruction remains the most frequently performed procedure, although autologous abdominal free tissue transfer has increased in popularity within specialist practice and the United Kingdom at large. These findings are reinforced by our own observations of the choices patients are making for IBR. Indeed, in our oncoplastic center, the number of LD flap reconstructions and especially implant-assisted LD procedures has significantly dwindled. Explanations for these shifting patterns in reconstructive practice and comparisons with data regarding IBR practice in the United States merit further discussion.
Comparison between UK and US Postmastectomy Reconstructive Practice
Trends in IBR in the United States and United Kingdom are summarized, compared, and contrasted in Figure 4. Similar to the UK trends highlighted (Table 3), data from the Surveillance, Epidemiology, and End Results (SEER) database suggest that IBR is increasing.3,14 Indeed, a recent analysis of data from the National Inpatient Sample (NIS) database suggested that IBR rates have increased by 78%, from 20.8% in 1998 to 37.8% in 2008.14
Fig. 4.
Longitudinal trends in proportions (% of total IBR) of each subtype of breast reconstruction performed in United Kingdom and United States. Charts depict proportional decrease in LD- and implant-based reconstruction and increase in autologous free flap reconstruction (A), and the opposing trend observed in an insured population in the United States (C).27 Conversely, the reduction in LD flap reconstruction and increase in DIEP or free flap microsurgery observed at the RMH (B) is mirrored in certain academic institutes in the United States (D).30 Autog indicates autologous; autog+, autologous plus implant. Procedural schematic illustrations reproduced with permission from http://www.breastreconstruction.org.
Although data suggest that implant-based reconstruction remains popular on both sides of the Atlantic, figures from the United States suggest rates of autologous reconstruction that are either stable or in decline.14–16 For example, Albornoz et al14 observed that although rates of autologous breast reconstruction were stable, implant reconstruction increased by approximately 11% per annum and a 5% year-on-year decrease in autologous reconstruction from 1998 to 2008.14,16 Similarly, Jagsi et al15 observed an increase in implant reconstruction and a corresponding decrease in the rate of autologous breast reconstruction from 56% in 1998 to 25% in 2007 and speculated that this might reflect patient preferences for simpler procedures, procedural complexity of microsurgical reconstruction, or financial disincentives that may complicate reconstructive decision making in the United States.15 For example, one study estimated that surgeons were reimbursed $587 per hour for implants and $322 per hour for autologous reconstructions. Others have suggested theater productivity and operating room bottlenecks may be to blame because in the time taken to conduct a free flap, several implant-based reconstructions may have been performed.14 The increase in bilateral mastectomy rates17,18 and the fact that bilateral (vs unilateral) was a predictor for implant reconstruction in the NIS study14 suggest that a desire for reconstructive symmetry may also play a role.
Finally, microsurgical skills training may be an issue. Kulkarni et al19 surveyed 500 active US members of the American Society of Plastics Surgeons and observed that only one fourth offered microsurgical reconstruction.19 This, notwithstanding, recent US data from Academic Institutions suggest patterns of reconstructive practice that more closely resemble the trends observed at the RMH.20 Specifically, Dasari et al20 identified an increase in autologous flap reconstruction from 2007 to 2013 and a longitudinal decline in LD reconstruction from 9.4 cases per surgeon in 2007 to 3.9 cases per surgeon in 2013.20
Role of New Technologies and Improvements in Autologous Reconstruction
We suspect that the recent decline in the proportion of LD-based reconstruction observed both locally and nationally may be influenced by technical improvements in both implant-only reconstruction and autologous abdominal techniques. The development of a range of ADMs that provide an extracellular scaffold to support musculofascial implant coverage enable revascularization and tissue integration as well as improving contour, shape, and ptosis is currently revolutionizing implant-based reconstruction. Emerging data suggest that implant reconstruction with ADM reduces the rates of capsular contracture and need for reoperative intervention and improves aesthetic outcomes versus two-stage submuscular tissue expansion.21,22 Proposals for systematic regulation of prostheses in the United Kingdom,23 the increase in contralateral mastectomy rates (hence elevated morbidity incurred from bilateral LD harvest),23 and evidence to support improved outcomes in the setting of radiotherapy24 are likely to sustain the observed popularity in implant-based reconstruction. Moreover, practical benefits include operating room utility and productivity. Critically, the operative time required for implant reconstruction using ADM is considerably shorter than that for an LD-based reconstruction.25 Similarly, the introduction of the DIEP flap has improved the complication profile of abdominal free tissue transfer with far lower rates of abdominal weakness and bulge compared with the pedicled-transverse rectus abdominis myocutaneous (p-TRAM) flap12 and superior patient satisfaction over LD reconstruction.26
Complication Profile and Role of LD Flap Reconstruction in Modern Practice
Postoperative complications of LD-based IBR such as donor-site seroma formation,4–8 breast animation,27,28 and functional shoulder weakness9–11 may have seen the LD fall out of favor in certain local centers and indeed in the United Kingdom nationally. Certainly, the results of curve fitting analysis suggest that there is a more recent decline in LD flap reconstruction. However, given that approximately 1000 LD flap reconstructions are performed every year (Table 3), a body of UK surgeons still believe that LD-based breast reconstruction has a role. In our view, there are specific circumstances in which deployment of the LD flap is especially useful. In particular, the extended LD flap provides an option for patients wishing to pursue autologous reconstruction, but in whom abdominal free tissue transfer is deemed unachievable (eg, damage to host perforators from previous abdominal surgery or slim individuals who lack a sufficient abdominal panniculus). Similarly, in patients considered to be too high risk for free flap reconstruction (eg, morbid obesity, smokers, diabetics), the LD flap has a superior complication profile.29
Patients undergoing extensive resection for locally advanced or locally recurrent breast cancer, with widespread cutaneous involvement or chest wall fixation require reconstruction to cover exposed vital structures, ensure timely closure to avoid delaying adjuvant therapy and improve quality of life.30,31 The LD flap is a useful salvage strategy in patients who have failed either implant-only reconstruction or autologous abdominal techniques. The LD “mini-flap” offers a tangible volume replacement option to maintain cosmesis in breast-conserving surgery,32,33 whereas endoscopic, robotic, muscle-sparing, and scarless techniques may facilitate IBR while simultaneously limiting donor complications.34,35
Strengths and Limitations
The strength of this study is in the ability to compare and contrast practice variation nationally, with those from a specialist oncoplastic center. There are recognized limitations intrinsic to administrative databases that may bias our results. Several codes were used for expanders and implants, and combinations of these codes often appeared in a single procedure. There is no code for ADM, which makes it impossible to confirm if the apparent popularity of implant-based reconstruction is being maintained by the benefits of this new technology. Finally, the absence of a DIEP-specific code before 2006 meant that any abdominal autologous reconstructions captured before that date were likely to reflect a heterogeneous combination of DIEP, TRAM, and/or superficial inferior epigastric artery (SIEA) flaps.
CONCLUSIONS
Implant-based breast reconstruction remains the most common reconstruction method in the United Kingdom. Autologous reconstruction with perforator flaps is more likely to be offered in specialist and academic institutions. A considerable number of LD flap reconstructions are still performed in England, which may reflect the access to such technical developments across the country leading to geographical variation in practice. Reconstructive surgeons should not be deskilled in LD flap reconstruction because it has a role in chest wall resurfacing, as a salvage reconstruction technique, and in patients deemed not to be suitable for either implant-only reconstruction or abdominal free-tissue transfer.
ACKNOWLEDGMENTS
We thank Carol Marlow and the coding team at the Royal Marsden Foundation NHS Trust for their time and support with this work.
Footnotes
Disclosure: The authors have no financial interest to declare in relation to the content of this article. The Article Processing Charge was paid for by the Imperial College London and the Royal Marsden NHS Foundation Trust.
REFERENCES
- 1.Zhong T, McCarthy C, Min S, et al. Patient satisfaction and health-related quality of life after autologous tissue breast reconstruction: a prospective analysis of early postoperative outcomes. Cancer. 2012;118:1701–1709. doi: 10.1002/cncr.26417. [DOI] [PubMed] [Google Scholar]
- 2.Health and Social Care Information Centre. National Mastectomy and Reconstruction Audit. 2011. Available at: http://www.hscic.gov.uk/. Accessed May 13, 2015.
- 3.Lang JE, Summers DE, Cui H, et al. Trends in post-mastectomy reconstruction: a SEER database analysis. J Surg Oncol. 2013;108:163–168. doi: 10.1002/jso.23365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Clough KB, Louis-Sylvestre C, Fitoussi A, et al. Donor site sequelae after autologous breast reconstruction with an extended latissimus dorsi flap. Plast Reconstr Surg. 2002;109:1904–1911. doi: 10.1097/00006534-200205000-00020. [DOI] [PubMed] [Google Scholar]
- 5.Menke H, Erkens M, Olbrisch RR. Evolving concepts in breast reconstruction with latissimus dorsi flaps: results and follow-up of 121 consecutive patients. Ann Plast Surg. 2001;47:107–114. doi: 10.1097/00000637-200108000-00001. [DOI] [PubMed] [Google Scholar]
- 6.Schwabegger A, Ninković M, Brenner E, et al. Seroma as a common donor site morbidity after harvesting the latissimus dorsi flap: observations on cause and prevention. Ann Plast Surg. 1997;38:594–597. doi: 10.1097/00000637-199706000-00005. [DOI] [PubMed] [Google Scholar]
- 7.Munhoz AM, Montag E, Fels KW, et al. Outcome analysis of breast-conservation surgery and immediate latissimus dorsi flap reconstruction in patients with T1 to T2 breast cancer. Plast Reconstr Surg. 2005;116:741–752. doi: 10.1097/01.prs.0000176251.15140.36. [DOI] [PubMed] [Google Scholar]
- 8.Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, et al. Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthet Surg. 2006;59:1017–1024. doi: 10.1016/j.bjps.2006.03.057. [DOI] [PubMed] [Google Scholar]
- 9.Thomson HJ, Potter S, Greenwood RJ, et al. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the influence of radiotherapy. Ann Surg Oncol. 2008;15:1081–1091. doi: 10.1245/s10434-007-9772-2. [DOI] [PubMed] [Google Scholar]
- 10.Forthomme B, Heymans O, Jacquemin D, et al. Shoulder function after latissimus dorsi transfer in breast reconstruction. Clin Physiol Funct Imaging. 2010;30:406–412. doi: 10.1111/j.1475-097X.2010.00956.x. [DOI] [PubMed] [Google Scholar]
- 11.Fraulin FO, Louie G, Zorrilla L, et al. Functional evaluation of the shoulder following latissimus dorsi muscle transfer. Ann Plast Surg. 1995;35:349–355. doi: 10.1097/00000637-199510000-00003. [DOI] [PubMed] [Google Scholar]
- 12.Egeberg A, Rasmussen MK, Sørensen JA. Comparing the donor-site morbidity using DIEP, SIEA or MS-TRAM flaps for breast reconstructive surgery: a meta-analysis. J Plast Reconstr Aesthet Surg. 2012;65:1474–1480. doi: 10.1016/j.bjps.2012.07.001. [DOI] [PubMed] [Google Scholar]
- 13.Salzberg CA, Ashikari AY, Koch RM, et al. An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm). Plast Reconstr Surg. 2011;127:514–524. doi: 10.1097/PRS.0b013e318200a961. [DOI] [PubMed] [Google Scholar]
- 14.Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15–23. doi: 10.1097/PRS.0b013e3182729cde. [DOI] [PubMed] [Google Scholar]
- 15.Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919–926. doi: 10.1200/JCO.2013.52.2284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hernandez-Boussard T, Zeidler K, Barzin A, et al. Breast reconstruction national trends and healthcare implications. Breast J. 2013;19:463–469. doi: 10.1111/tbj.12148. [DOI] [PubMed] [Google Scholar]
- 17.Tuttle TM, Abbott A, Arrington A, et al. The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep. 2010;12:16–21. doi: 10.1007/s11912-009-0070-y. [DOI] [PubMed] [Google Scholar]
- 18.Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–5209. doi: 10.1200/JCO.2007.12.3141. [DOI] [PubMed] [Google Scholar]
- 19.Kulkarni AR, Sears ED, Atisha DM, et al. Use of autologous and microsurgical breast reconstruction by U.S. plastic surgeons. Plast Reconstr Surg. 2013;132:534–541. doi: 10.1097/PRS.0b013e31829ae03e. [DOI] [PubMed] [Google Scholar]
- 20.Dasari CR, Gunther S, Wisner DH, et al. Rise in microsurgical free-flap breast reconstruction in academic medical practices. Ann Plast Surg. 2015;74(Suppl 1):S62–S65. doi: 10.1097/SAP.0000000000000483. [DOI] [PubMed] [Google Scholar]
- 21.Spear SL, Newman MK, Bedford MS, et al. A retrospective analysis of outcomes using three common methods for immediate breast reconstruction. Plast Reconstr Surg. 2008;122:340–347. doi: 10.1097/PRS.0b013e31817d6009. [DOI] [PubMed] [Google Scholar]
- 22.Glasberg SB, Light D. AlloDerm and Strattice in breast reconstruction: a comparison and techniques for optimizing outcomes. Plast Reconstr Surg. 2012;129:1223–1233. doi: 10.1097/PRS.0b013e31824ec429. [DOI] [PubMed] [Google Scholar]
- 23.Department of Health. Review of the Regulation of Cosmetic Interventions. 2013. Available at: https://www.gov.uk. Accessed May 13, 2015.
- 24.Seth AK, Hirsch EM, Fine NA, et al. Utility of acellular dermis-assisted breast reconstruction in the setting of radiation: a comparative analysis. Plast Reconstr Surg. 2012;130:750–758. doi: 10.1097/PRS.0b013e318262f009. [DOI] [PubMed] [Google Scholar]
- 25.Johnson RK, Wright CK, Gandhi A, et al. Cost minimisation analysis of using acellular dermal matrix (Strattice™) for breast reconstruction compared with standard techniques. Eur J Surg Oncol. 2013;39:242–247. doi: 10.1016/j.ejso.2012.12.002. [DOI] [PubMed] [Google Scholar]
- 26.Yueh JH, Slavin SA, Adesiyun T, et al. Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg. 2010;125:1585–1595. doi: 10.1097/PRS.0b013e3181cb6351. [DOI] [PubMed] [Google Scholar]
- 27.Dancey AL, Cheema M, Thomas SS. A prospective randomized trial of the efficacy of marginal quilting sutures and fibrin sealant in reducing the incidence of seromas in the extended latissimus dorsi donor site. Plast Reconstr Surg. 2010;125:1309–1317. doi: 10.1097/PRS.0b013e3181d4fb68. [DOI] [PubMed] [Google Scholar]
- 28.Szychta P, Butterworth M, Dixon M, et al. Breast reconstruction with the denervated latissimus dorsi musculocutaneous flap. Breast. 2013;22:667–672. doi: 10.1016/j.breast.2013.01.001. [DOI] [PubMed] [Google Scholar]
- 29.Yezhelyev M, Duggal CS, Carlson GW, et al. Complications of latissimus dorsi flap breast reconstruction in overweight and obese patients. Ann Plast Surg. 2013;70:557–562. doi: 10.1097/SAP.0b013e31827a2c02. [DOI] [PubMed] [Google Scholar]
- 30.Beahm EK, Chang DW. Chest wall reconstruction and advanced disease. Semin Plast Surg. 2004;18:117–129. doi: 10.1055/s-2004-829046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Veronesi G, Scanagatta P, Goldhirsch A, et al. Results of chest wall resection for recurrent or locally advanced breast malignancies. Breast. 2007;16:297–302. doi: 10.1016/j.breast.2006.12.008. [DOI] [PubMed] [Google Scholar]
- 32.Dixon JM, Venizelos B, Chan P. Latissimus dorsi mini-flap: a technique for extending breast conservation. Breast. 2002;11:58–65. doi: 10.1054/brst.2001.0312. [DOI] [PubMed] [Google Scholar]
- 33.Rusby JE, Paramanathan N, Laws SA, et al. Immediate latissimus dorsi miniflap volume replacement for partial mastectomy: use of intra-operative frozen sections to confirm negative margins. Am J Surg. 2008;196:512–518. doi: 10.1016/j.amjsurg.2008.06.026. [DOI] [PubMed] [Google Scholar]
- 34.Elliott LF, Ghazi BH, Otterburn DM. The scarless latissimus dorsi flap for full muscle coverage in device-based immediate breast reconstruction: an autologous alternative to acellular dermal matrix. Plast Reconstr Surg. 2011;128:71–79. doi: 10.1097/PRS.0b013e318218fcc6. [DOI] [PubMed] [Google Scholar]
- 35.Mishra A, Brackley PT, Sigaroudina M, et al. Muscle-sparing latissimus dorsi technique for breast reconstruction. Plast Reconstr Surg. 2010;125:1295–author reply 1295–1297. doi: 10.1097/PRS.0b013e3181d45bac. [DOI] [PubMed] [Google Scholar]